Table 2 Interview questions asked of health facility officers in charge
1. Please describe the methods this facility uses to monitor HIV drug resistance for the pediatric population. a. What challenges, if any, have you experienced using these methods to monitor drug resistance? b. What are the positive aspects of using these methods to monitor drug resistance? 2. How effective has any of these drug resistance monitoring systems been in identifying possible drug resistance in the pediatric population? 3. Please describe any standards and procedures regarding conducting pill counts with pediatric ART patients at this facility. a. What challenges or barriers does this facility experience regarding conducting pill counts with pediatric ART patients? b. How can these barriers or challenges be addressed? 4. Please describe any standards and procedures regarding the conduct of adherence counseling with pediatric ART patients at this facility. a. What challenges or barriers does this facility experience regarding conducting adherence counseling with pediatric ART patients? b. How can these barriers or challenges be addressed? 5. Please describe any standards and procedures for tracking or tracing pediatric ART patients who miss appointments and drug pickups at this facility. a. What challenges or barriers does this facility experience regarding tracking or tracing ART patients? What about among the pediatric ART patients? b. How can these barriers or challenges be addressed? 6. Does this facility have the equipment and qualified staff to conduct viral load testing? If yes, a. Please describe any challenges or barriers to conducting routine viral load testing at this facility. b. In your opinion, how can these barriers or challenges be addressed? c. What works best in conducting routing viral load testing? If no, a. Please describe the procedures regarding viral load testing with pediatric patients? b. What challenges or barriers does this facility encounter with viral load testing? c. In your opinion, how can these barriers or challenges be addressed? d. What works best in conducting routing viral load testing? 7. Please describe how the current facility practices regarding pill counts, adherence counseling, and/or patient tracing may affect the quality of records needed for pediatric ART monitoring at this facility. 8. Overall, are the ART medical and pharmaceutical records at this facility well-maintained, or are there some gaps in recording the necessary information? a. Please describe any factors or challenges to maintaining complete and up-to-date ART records. 9. What interventions would you recommend to improve routine EWI monitoring at your facility? |